Jin Lei, Chen Jiezhong, Liu Xiao Ying, Jiang Chen Chen, Zhang Xu Dong
School of Medicine and Public Health, The University of Newcastle , NSW, Australia.
School of Biomedical Sciences and Pharmacy, The University of Newcastle , NSW, Australia.
Mol Cell Oncol. 2015 May 26;3(1):e1035690. doi: 10.1080/23723556.2015.1035690. eCollection 2016 Jan.
We have recently identified receptor (TNFRSF)-interacting serine-threonine kinase 1 (RIPK1) as an oncogenic driver in melanoma in addition to its well-established role in controlling cell survival and death. Our studies show that RIPK1 promotes melanoma cell proliferation through a positive feedback loop of NFKB1-BIRC2/BIRC3-RIPK1 powered by autocrine tumor necrosis factor.
我们最近发现,受体(TNFRSF)相互作用丝氨酸 - 苏氨酸激酶1(RIPK1)除了在控制细胞存活和死亡方面已确立的作用外,还是黑色素瘤的致癌驱动因素。我们的研究表明,RIPK1通过由自分泌肿瘤坏死因子驱动的NFKB1 - BIRC2 / BIRC3 - RIPK1正反馈回路促进黑色素瘤细胞增殖。